Infumorph 500 Injection, Solution
Product Images NDC 0641-6040

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Infumorph 500 (NDC 0641-6040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fiigure From Plr (Infumorph 1)

A line chart titled 'Dose Trend in Continuous Infusions of Intrathecal Morphine' showing infusion dose in mg/day on the y-axis versus infusion duration in weeks on the x-axis. The graph includes a mean trend line with a surrounding shaded area representing 95% confidence intervals. A horizontal reference line is marked at 20 mg/day, noted as the lowest dose associated with regional myoclonus.*

FDA Label Image

Structure (Infumorph 2)

Chemical structure diagram of morphine sulfate pentahydrate, showing the molecular arrangement including aromatic rings, hydroxyl groups, and sulfate with associated water molecules. The structure is consistent with morphine sulfate as the active ingredient.*

FDA Label Image

Infumorph 200 (preservative-free Morphine Sulfate Sterile Solution) Cii 200 mg/20 mL (10 mg/ml) 20 mL Ampul Ampul Label (Infumorph 3)

Infumorph 200 preservative-free morphine sulfate sterile solution injection, 200 mg per 20 mL (10 mg/mL) in a 20 mL single-dose ampul. Label indicates it is for neuraxial administration in continuous microinfusion devices, not for IV, IM, or subcutaneous injection. Manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

462-214-02 (Infumorph 4)

Infumorph 200 Injection, Solution label showing morphine sulfate 200 mg per 20 mL (10 mg/mL) strength in a preservative-free sterile solution. The label includes warnings against intravenous, intramuscular, or subcutaneous injection and states it is for neuraxial administration in continuous microinfusion devices. The product is a single dose 20 mL ampul by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Infumorph 500 (preservative-free Morphine Sulfate Solution) Cii 500 mg/20 mL (25 mg/ml) 20 mL Ampul Ampul Label (Infumorph 5)

Label for Infumorph 500 injection solution, preservative-free morphine sulfate sterile solution with a concentration of 500 mg per 20 mL (25 mg/mL). The 20 mL single-dose ampul is for neuraxial administration in continuous microinfusion devices and is not for IV, IM, or subcutaneous injection. Manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

462-216-02 (Infumorph 6)

The packaging label for Infumorph 500 injection, solution contains 500 mg morphine sulfate per 20 mL (25 mg/mL). It is labeled as a preservative-free sterile solution for epidural and intrathecal use, supplied as a 20 mL single-dose ampul. The label includes usage restrictions, specifying it is not for intravenous, intramuscular, or subcutaneous injection, and notes it is for neuraxial administration in continuous microinfusion devices. The labeler is Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Layout 1 (Infumorph 7)

A product label for INFUMORPH 500 morphine sulfate injection solution. The label includes a QR code and printed information with GTIN, serial number, expiration date placeholder, and lot number placeholder. The label shows standard serialization and traceability details typically used for human prescription drugs by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.